PharmaResources (Shanghai) Co. Ltd. A (301230) - Total Liabilities

Latest as of March 2026: CN¥285.89 Million CNY ≈ $41.83 Million USD

Based on the latest financial reports, PharmaResources (Shanghai) Co. Ltd. A (301230) has total liabilities worth CN¥285.89 Million CNY (≈ $41.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of PharmaResources (Shanghai) Co. Ltd. A to track the company's year-over-year net asset growth rate.

PharmaResources (Shanghai) Co. Ltd. A - Total Liabilities Trend (2020–2025)

This chart illustrates how PharmaResources (Shanghai) Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See PharmaResources (Shanghai) Co. Ltd. A free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

PharmaResources (Shanghai) Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of PharmaResources (Shanghai) Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
GREENLIGHT CAP.RE A DL-01 F:G8L	Germany	€1.53 Billion
Hyster-Yale Materials Handling Inc NYSE:HY	USA	$1.51 Billion
Shenzhen Etmade Automatic Equipment SHE:300812	China	CN¥548.90 Million
Fulgent Genetics Inc NASDAQ:FLGT	USA	$112.22 Million
Shanghai Shen Lian Biomedical Corp SHG:688098	China	CN¥133.33 Million
Jiangxi Tianli Technology INC SHE:300399	China	CN¥246.55 Million
Shenzhen Nanshan Power Co Ltd SHE:000037	China	CN¥551.60 Million
Nagarro SE XETRA:NA9	Germany	€587.94 Million

Liability Composition Analysis (2020–2025)

This chart breaks down PharmaResources (Shanghai) Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 301230 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PharmaResources (Shanghai) Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)

The table below shows the annual total liabilities of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥309.87 Million ≈ $45.34 Million	+9.21%
2024-12-31	CN¥283.73 Million ≈ $41.52 Million	-23.24%
2023-12-31	CN¥369.62 Million ≈ $54.09 Million	+96.21%
2022-12-31	CN¥188.38 Million ≈ $27.57 Million	-10.03%
2021-12-31	CN¥209.37 Million ≈ $30.64 Million	+88.93%
2020-12-31	CN¥110.81 Million ≈ $16.22 Million	--

About PharmaResources (Shanghai) Co. Ltd. A

SHE:301230 China Biotechnology

Market Cap

$500.03 Million

CN¥3.42 Billion CNY

Market Cap Rank

#12069 Global

#3446 in China

Share Price

CN¥24.48

Change (1 day)

+0.16%

52-Week Range

CN¥22.55 - CN¥65.76

All Time High

CN¥65.76